Atrial Fibrillation

被引：1

作者：

Bontempo, Laura J. ^{[1
]}

Goralnick, Eric ^{[2
,3
]}

机构：

[1] Yale Univ, Dept Emergency Med, New Haven, CT 06519 USA

[2] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Boston, MA 02115 USA

来源：

EMERGENCY MEDICINE CLINICS OF NORTH AMERICA | 2011年 / 29卷 / 04期

关键词：

Atrial fibrillation; Atrial flutter; Heart; Dysrhythmia; EMERGENCY-DEPARTMENT; SINUS RHYTHM; FOLLOW-UP; ANTITHROMBOTIC THERAPY; INTRAVENOUS FLECAINIDE; STROKE PREVENTION; RISK-FACTORS; MANAGEMENT; CARDIOVERSION; ANTICOAGULATION;

D O I：

10.1016/j.emc.2011.08.008

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Atrial fibrillation (AF) results from the chaotic depolarization of atrial tissue and is the most common dysrhythmia diagnosed in United States (US) emergency departments. AF affects greater than 1% of the general population, with a peak prevalence of 10% in those greater than 80 years of age. By 2050, it is estimated that nearly 16 million US patients will suffer from AF. AF has significant health effects, and places a considerable economic burden on the health care system. This article discusses recommendations that are derived from a combination of existing guidelines, additional evidence, and consensus.

引用

页码：747 / +

页数：13

共 50 条

[41] Catheter ablation of atrial fibrillation to reduce stroke risk
Schmidt, B.
Bordignon, S.
Fuernkranz, A.
Chun, K. R. J.
HERZ, 2013, 38 (03) : 247 - 250
[42] The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease
Franczyk, Beata
Gluba-Brzozka, Anna
Cialkowska-Rysz, Aleksandra
Banach, Maciej
Rysz, Jacek
CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (03) : 260 - 265
[43] Update on the Clinical Management of Atrial Fibrillation: Guidelines and Beyond
Curtis, Anne B.
POSTGRADUATE MEDICINE, 2011, 123 (06) : 7 - 20
[44] Advances in the prevention of cerebral ischaemia due to atrial fibrillation
Gil Nunez, A.
NEUROLOGIA, 2010, 25 (07): : 401 - 408
[45] Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?
Overvad, Thure Filskov
Skjoth, Flemming
Albertsen, Ida Ehlers
Larsen, Torben Bjerregaard
Sogaard, Mette
Lip, Gregory Y. H.
AMERICAN JOURNAL OF MEDICINE, 2021, 134 (01) : 67 - +
[46] Assessing the Risk of Bleeding in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project
Lip, Gregory Y. H.
Banerjee, Amitava
Lagrenade, Isabelle
Lane, Deirdre A.
Taillandier, Sophie
Fauchier, Laurent
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (05) : 941 - 948
[47] Risks and Benefits of Anticoagulation in Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry
Cullen, Michael W.
Kim, Sunghee
Piccini, Jonathan P.
Ansell, Jack E.
Fonarow, Greg C.
Hylek, Elaine M.
Singer, Daniel E.
Mahaffey, Kenneth W.
Kowey, Peter R.
Thomas, Laine
Go, Alan S.
Lopes, Renato D.
Chang, Paul
Peterson, Eric D.
Gersh, Bernard J.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (04): : 461 - 469
[48] Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records
Rosenman, Marc B.
Baker, Layla
Jing, Yonghua
Makenbaeva, Dinara
Meissner, Brian
Simon, Teresa A.
Wiederkehr, Daniel
Deitelzweig, Steve
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (09) : 1407 - 1414
[49] Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival
Khurshid, Shaan
Akerman, Simon
Man, Jonathan P.
Supple, Gregory
Dixit, Sanjay
Epstein, Andrew E.
Marchlinski, Francis E.
Frankel, David S.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2015, 42 (02) : 117 - 124
[50] New Antithrombotics for Atrial Fibrillation
Bereznicki, Luke R. E.
Peterson, Gregory M.
CARDIOVASCULAR THERAPEUTICS, 2010, 28 (05) : 278 - 286

← 1 2 3 4 5 →